BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30540681)

  • 21. Surgical strategy for intraductal papillary mucinous neoplasms of the pancreas.
    Hirono S; Yamaue H
    Surg Today; 2020 Jan; 50(1):50-55. PubMed ID: 31807871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are preoperative blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios useful in predicting malignancy in surgically-treated mucin-producing pancreatic cystic neoplasms?
    Goh BK; Tan DM; Chan CY; Lee SY; Lee VT; Thng CH; Low AS; Tai DW; Cheow PC; Chow PK; Ooi LL; Chung AY
    J Surg Oncol; 2015 Sep; 112(4):366-71. PubMed ID: 26280242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetes mellitus in intraductal papillary mucinous neoplasm of the pancreas is associated with high-grade dysplasia and invasive carcinoma.
    Morales-Oyarvide V; Mino-Kenudson M; Ferrone CR; Sahani DV; Pergolini I; Negreros-Osuna AA; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
    Pancreatology; 2017; 17(6):920-926. PubMed ID: 28890154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma.
    Zhang Y; Jiang C; Li J; Sun J; Qu X
    Clin Transl Oncol; 2015 Oct; 17(10):810-8. PubMed ID: 26077119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison between intraductal papillary neoplasms of the biliary tract (BT-IPMNs) and intraductal papillary mucinous neoplasms of the pancreas (P-IPMNs) reveals distinct clinical manifestations and outcomes.
    Minagawa N; Sato N; Mori Y; Tamura T; Higure A; Yamaguchi K
    Eur J Surg Oncol; 2013 Jun; 39(6):554-8. PubMed ID: 23506840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyst fluid carcinoembryonic antigen level is not predictive of invasive cancer in patients with intraductal papillary mucinous neoplasm of the pancreas.
    Kucera S; Centeno BA; Springett G; Malafa MP; Chen YA; Weber J; Klapman J
    JOP; 2012 Jul; 13(4):409-13. PubMed ID: 22797397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases.
    Nara S; Onaya H; Hiraoka N; Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T
    Pancreas; 2009 Jan; 38(1):8-16. PubMed ID: 18665010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The diagnostic and prognostic values of inflammatory markers in intraductal papillary mucinous neoplasm.
    Kim H; Jung W; Chan Shin Y; Han IW; Byun Y; Lee HW; Heo JS; Choi DW; Lim CS
    HPB (Oxford); 2021 Oct; 23(10):1623-1628. PubMed ID: 34001453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of each high-risk stigmata and worrisome features as a predictor of high-grade dysplasia in intraductal papillary mucinous neoplasms of the pancreas.
    Izumo W; Higuchi R; Furukawa T; Yazawa T; Uemura S; Shiihara M; Yamamoto M
    Pancreatology; 2020 Jul; 20(5):895-901. PubMed ID: 32624417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging role of tumor markers and biochemistry in the preoperative invasive assessment of intraductal papillary mucinous neoplasm of the pancreas.
    You L; Ma L; Zhao WJ; Zhao YP; Dai MH
    Clin Chim Acta; 2016 Feb; 454():89-93. PubMed ID: 26746574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative histological subtype classification of intraductal papillary mucinous neoplasms (IPMN) by pancreatic juice cytology with MUC stain.
    Hara T; Ikebe D; Odaka A; Sudo K; Nakamura K; Yamamoto H; Itami M; Hirata T; Kashimura J; Yamaguchi T
    Ann Surg; 2013 Jun; 257(6):1103-11. PubMed ID: 23364699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of early stages of histological progression of branch duct IPMN.
    Kurahara H; Maemura K; Mataki Y; Sakoda M; Iino S; Kijima Y; Ishigami S; Ueno S; Shinchi H; Natsugoe S
    Langenbecks Arch Surg; 2015 Jan; 400(1):49-56. PubMed ID: 25445160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Clinical Indications for Limited Surgery of Intraductal Papillary Mucinous Neoplasms of the Pancreas.
    Kimura K; Amano R; Ymazoe S; Ohira G; Nishio K; Hirakawa K; Ohira M
    World J Surg; 2017 May; 41(5):1358-1365. PubMed ID: 27882420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Ratio of C-Reactive Protein to Albumin Is an Independent Predictor of Malignant Intraductal Papillary Mucinous Neoplasms of the Pancreas.
    Serafini S; Friziero A; Sperti C; Vallese L; Grego A; Piangerelli A; Belluzzi A; Moletta L
    J Clin Med; 2021 May; 10(10):. PubMed ID: 34064877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostaglandin E
    Yip-Schneider MT; Carr RA; Wu H; Schmidt CM
    J Am Coll Surg; 2017 Oct; 225(4):481-487. PubMed ID: 28739154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value of adding GNAS testing to pancreatic cyst fluid KRAS and carcinoembryonic antigen analysis for the diagnosis of intraductal papillary mucinous neoplasms.
    Kadayifci A; Atar M; Wang JL; Forcione DG; Casey BW; Pitman MB; Brugge WR
    Dig Endosc; 2017 Jan; 29(1):111-117. PubMed ID: 27514845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive Factors for the Metachronous Development of High-risk Lesions in the Remnant Pancreas After Partial Pancreatectomy for Intraductal Papillary Mucinous Neoplasm.
    Miyasaka Y; Ohtsuka T; Tamura K; Mori Y; Shindo K; Yamada D; Takahata S; Ishigami K; Ito T; Tokunaga S; Oda Y; Mizumoto K; Nakamura M; Tanaka M
    Ann Surg; 2016 Jun; 263(6):1180-7. PubMed ID: 26334637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of pre-operative neutrophil/lymphocyte ratio, monocyte count, mean platelet volume, and platelet/lymphocyte ratio in endometrial cancer.
    Temur I; Kucukgoz Gulec U; Paydas S; Guzel AB; Sucu M; Vardar MA
    Eur J Obstet Gynecol Reprod Biol; 2018 Jul; 226():25-29. PubMed ID: 29804024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors Associated With Invasive Intraductal Papillary Mucinous Carcinoma of the Pancreas.
    Hirono S; Kawai M; Okada KI; Miyazawa M; Shimizu A; Kitahata Y; Ueno M; Yanagisawa A; Yamaue H
    JAMA Surg; 2017 Mar; 152(3):e165054. PubMed ID: 28122068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiogenesis index CD105 (endoglin)/CD31 (PECAM-1) as a predictive factor for invasion and proliferation in intraductal papillary mucinous neoplasm (IPMN) of the pancreas.
    Tachezy M; Reichelt U; Melenberg T; Gebauer F; Izbicki JR; Kaifi JT
    Histol Histopathol; 2010 Oct; 25(10):1239-46. PubMed ID: 20712008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.